Nationwide Fund Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-78,383
| Closed | -$480K | – | 2799 |
|
|
2017
Q3 | $480K | Hold |
78,383
| – | – | ﹤0.01% | 2209 |
|
|
2017
Q2 | $567K | Buy |
78,383
+26,130
| +50% | +$189K | ﹤0.01% | 2114 |
|
|
2017
Q1 | $277K | Sell |
52,253
-1,435
| -3% | -$7.61K | ﹤0.01% | 2452 |
|
|
2016
Q4 | $385K | Sell |
53,688
-10,763
| -17% | -$77.2K | ﹤0.01% | 2318 |
|
|
2016
Q3 | $603K | Buy |
64,451
+12,705
| +25% | +$119K | ﹤0.01% | 2082 |
|
|
2016
Q2 | $327K | Hold |
51,746
| – | – | ﹤0.01% | 2371 |
|
|
2016
Q1 | $286K | Hold |
51,746
| – | – | ﹤0.01% | 2368 |
|
|
2015
Q4 | $289K | Buy |
51,746
+802
| +2% | +$4.48K | ﹤0.01% | 2373 |
|
|
2015
Q3 | $431K | Buy |
50,944
+31,348
| +160% | +$265K | ﹤0.01% | 2201 |
|
|
2015
Q2 | $296K | Sell |
19,596
-1,531
| -7% | -$23.1K | ﹤0.01% | 2509 |
|
|
2015
Q1 | $338K | Sell |
21,127
-536
| -2% | -$8.58K | ﹤0.01% | 2445 |
|
|
2014
Q4 | $386K | Buy |
21,663
+1,804
| +9% | +$32.1K | ﹤0.01% | 2335 |
|
|
2014
Q3 | $199K | Buy |
19,859
+1,335
| +7% | +$13.4K | ﹤0.01% | 2692 |
|
|
2014
Q2 | $289K | Buy |
18,524
+12,497
| +207% | +$195K | ﹤0.01% | 2549 |
|
|
2014
Q1 | $112K | Buy |
6,027
+973
| +19% | +$18.1K | ﹤0.01% | 2717 |
|
|
2013
Q4 | $97K | Buy |
5,054
+3,146
| +165% | +$60.4K | ﹤0.01% | 2961 |
|
|
2013
Q3 | $31K | Buy |
+1,908
| New | +$31K | ﹤0.01% | 3072 |
|